Case Report

Published on 24 Dec 2024

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

in Cancer Immunity and Immunotherapy

Ying Sun
Guanghui Yang
Ruijie Sun
Fangli Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1462993

127 views

Case Report

Published on 24 Dec 2024

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges

in Cancer Immunity and Immunotherapy

Chengwei Jin
Hong Ge
Dongsheng Hou
Jing Li
Mingming Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1515240

170 views

Review

Accepted on 23 Dec 2024

Innovative Applications and Future Trends of Multiparametric PET in the Assessment of Immunotherapy Efficacy

in Cancer Immunity and Immunotherapy

Tingting Qiao
Yanhua Duan
Zhaoping Cheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1530507

Systematic Review

Published on 23 Dec 2024

Prognostic significance of systemic immune inflammation index in patients with urothelial carcinoma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Lei Zheng
Zuoping Wang
Yunxiang Li
Si Ge
Zhiqiang Zeng
Lijian Gan
Chunyang Meng
Kangsen Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1469444

187 views

Mini Review

Accepted on 20 Dec 2024

Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Huang Yuxiang
Huang Junqi
Liao Hengjian
Luo Jiefu
Wei Huaning
Li Anling
Lu Yujie
Xiang Bangde
Xie Yuan

Frontiers in Oncology

doi 10.3389/fonc.2024.1502270

Mini Review

Accepted on 20 Dec 2024

Advanced progress in the genetic modification of the oncolytic HSV-1 virus

in Cancer Immunity and Immunotherapy

Mi Zhou
Shen Zhenyu

Frontiers in Oncology

doi 10.3389/fonc.2024.1525940

Review

Accepted on 20 Dec 2024

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Zhi yong Wan
meng cui
jia yang
dan liao
jun liang chen
fan min li
yin xiang
zhi wei xiang
yang yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1531219

Review

Published on 20 Dec 2024

10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer

in Cancer Immunity and Immunotherapy

Solange R. Paredes-Moscosso
Amit C. Nathwani

Frontiers in Oncology

doi 10.3389/fonc.2024.1429330

329 views

Case Report

Published on 20 Dec 2024

Successful treatment of recurrent refractory Kaposi’s sarcoma in AIDS: a case report

in Cancer Immunity and Immunotherapy

Feng Li
Rongrong Zheng
Jun Yan
Zhongdong Zhang
Hong Liu
Jinchuan Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1462381

205 views

Original Research

Accepted on 19 Dec 2024

Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker

in Cancer Immunity and Immunotherapy

Wenya Xing
Yuanzi Zhou
Qiuzi Long
Nan Yi
Gaoyuan Wang
Rongwei Shi
Jinlong Huang
Xindong Yin
Taiyang Zhu
Shibing Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1511958

125 views

Original Research

Accepted on 19 Dec 2024

CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment

in Cancer Immunity and Immunotherapy

Tingting Du
Jialin Zou
Yunying Yang
Honghui Xie
Hui Pang
Wenquan Zhuang
Shutong Wang
Guangyan Wei

Frontiers in Oncology

doi 10.3389/fonc.2024.1528138

Original Research

Published on 19 Dec 2024

Gut virome dysbiosis impairs antitumor immunity and reduces 5-fluorouracil treatment efficacy for colorectal cancer

in Cancer Immunity and Immunotherapy

Hui Huang
Ying Yang
Xiaojiao Wang
Biao Wen
Xianglan Yang
Wei Zhong
Qiurong Wang
Feng He
Jun Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1501981

144 views

Original Research

Published on 17 Dec 2024

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China

in Cancer Immunity and Immunotherapy

Caicong You
Jiahao Zhang
Jianying Lei
Wu Fu
Bin Zheng
Maobai Liu
Na Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1484650

207 views

Original Research

Published on 17 Dec 2024

The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Yuyan Xie
Hao Sun
Liying Shan
Xin Ma
Qingyu Sun
Fang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1454709

230 views

Original Research

Accepted on 16 Dec 2024

DET induces apoptosis and suppresses tumor invasion in glioma cells via PI3K/AKT pathway

in Cancer Immunity and Immunotherapy

Rui Zhao
Mengran Wang
Zeyu Wu
Panpan Zhao
Huiling Dong
Yue Su
Chenghui Zhao
Min Qi
Shizhang Ling
Xiaochun Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1528454

Case Report

Accepted on 16 Dec 2024

Long-Term Disease Control in Dedifferentiated Liposarcoma: A Case Report on Trabectedin Priming Followed by PD-1 Inhibition

in Cancer Immunity and Immunotherapy

Johannes M. Waldschmidt
Lukas Haug
Christine Riedhammer
Christoph K. W. Deinzer
Marcus Zimmermann
Anke Heidemeier
Anne Hendricks
Andreas Rosenwald
Hermann Einsele
Peter Reichardt

Frontiers in Oncology

doi 10.3389/fonc.2024.1518775

Navigation group

Articles

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges

Innovative Applications and Future Trends of Multiparametric PET in the Assessment of Immunotherapy Efficacy

Prognostic significance of systemic immune inflammation index in patients with urothelial carcinoma: a systematic review and meta-analysis

Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma

Advanced progress in the genetic modification of the oncolytic HSV-1 virus

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer

Successful treatment of recurrent refractory Kaposi’s sarcoma in AIDS: a case report

Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker

CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment

Gut virome dysbiosis impairs antitumor immunity and reduces 5-fluorouracil treatment efficacy for colorectal cancer

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China

The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma

DET induces apoptosis and suppresses tumor invasion in glioma cells via PI3K/AKT pathway

Long-Term Disease Control in Dedifferentiated Liposarcoma: A Case Report on Trabectedin Priming Followed by PD-1 Inhibition